Table 2.
Vital signs and laboratory findings of the study patients at the time of ICU admission
| Overall | CMV reactivation | |||
|---|---|---|---|---|
| N = 71 | Yes (n = 13, 18.3%) | No (n = 58, 81.7%) | P | |
| Basic Vital Signs | ||||
| Average Blood Pressure (mmHg) | 92 (82–103) | 95 (90–103) | 92 (80–102) | 0.36 |
| Heart Rate (bp) | 110 ± 26 | 115 ± 26 | 109 ± 27 | 0.47 |
| Respiratory Rate (t/m) | 23 (20–26) | 26 (19–26) | 23 (20–26) | 0.89 |
| Temperature (℃) | 36.8 (36.6–37.2) | 36.6 (36.6–37.2) | 36.9 (36.6–37.2) | 0.43 |
| SPO2 (%) | 97 (95–99) | 97 (96–98) | 97 (95–99) | 0.88 |
| Laboratory Findings | ||||
| P/F | 234 ± 94 | 217 ± 76 | 238 ± 97 | 0.49 |
| Nt-proBNP (pg/mL)a | 2499 (611–8207) | 7745 (2869–19,376) | 1805 (500–7561) | 0.01 |
| AST (U/L) | 42.6 (30.0–85.9) | 41.0 (28.0–85.9) | 42.8 (30.0–81.1) | 0.63 |
| ALT (U/L) | 25.5 (15.2–53.7) | 26.5 (10.2–55.9) | 24.4 (15.3–50.5) | 0.94 |
| T-BIL(μmol/L) | 14.0 (9.7–35.1) | 10.9 (9.1–17.2) | 15.2 (10.2–39.6) | 0.13 |
| Scr (μmol/L) | 130 (70–223) | 133 (70–205) | 128 (70–223) | 0.95 |
| BUN (mmol/L)a | 9.3 (5.7–15.4) | 13.6 (10.8–20.7) | 8.6 (5.7–14.1) | 0.03 |
| PT (s) | 16 (15–17) | 16 (15–17) | 16 (15–17) | 0.82 |
| APTT (s) | 41 (36–48) | 43 (36–49) | 41 (36–47) | 0.67 |
| PCT (ng/mL) | 0.9 (0.2–7.7) | 2.5 (0.3–10.8) | 0.9 (0.2–7.4) | 0.36 |
| Hypersensitive CRP (mg/L) | 107 (32–142) | 107 (68–130) | 98 (26–142) | 0.34 |
| ESR (mm/h) | 45 (18–85) | 42 (17–75) | 45 (18–85) | 0.81 |
| G Test (pg/mL) | 14.9 (0–47.8) | 21.1 (0–56.5) | 10.4 (0–45.2) | 0.50 |
| GM Test (Aspergillus) (μg/L) | 0.33 (0–0.44) | 0.32 (0.28–0.37) | 0.36 (0–0.44) | 0.71 |
| GM Test (Cryptococcus), n (%) | 5 (7.0) | 0 (0) | 5 (8.6) | 0.58 |
| White Blood Cells (109/L) | 12.5 (8.9–17.1) | 14.8 (11.2–20.5) | 12.4 (8.9–15.9) | 0.28 |
| Neutrophils (109/L) | 11.3 (7.6–15.4) | 13.3 (10.6–19.4) | 11.1 (7.6–14.8) | 0.22 |
| Lymphocytes (109/L) | 0.4 (0.3–0.9) | 0.4 (0.2–0.5) | 0.5 (0.3–0.9) | 0.19 |
| Monocytes (109/L) | 0.7 (0.4–1.0) | 0.4 (0.2–0.9) | 0.7 (0.4–1.0) | 0.16 |
| Eosinophils (109/L) | 0 (0–0.01) | 0 (0–0.01) | 0 (0–0) | 0.32 |
| Basophils (109/L) | 0 (0–0.02) | 0 (0–0.04) | 0 (0–0.01) | 0.33 |
| Erythrocyte (1012/L) | 3.40 ± 0.85 | 3.05 ± 0.79 | 3.52 ± 0.84 | 0.07 |
| Hemoglobin (g/L)a | 102 (82–118) | 98 (70–102) | 104 (88–121) | 0.03 |
| Platelet (109/L) | 177 ± 91 | 190 ± 116 | 174 ± 86 | 0.65 |
aP < 0.05. Continuous variables were expressed as Mean ± SD or Median (IQRs); Bold font indicates the difference was statistically significant. SPO2 Arterial oxygen saturation, P/F (PaO2/FiO2) the ratio between the arterial partial pressure of oxygen and the inspiratory concentration of oxygen, Nt-proBNP N-terminal Pro-B-type Natriuretic Peptide; AST Aspartate Aminotransferase, ALT Alanine Transaminase, T-BIL Total Bilirubin, Scr Serum Creatinine, BUN Serum Urea Nitrogen; PT: Prothrombin Time; APTT: Activated Partial Thromboplastin Time, PCT Procalcitonin, CRP C-reactive Protein, ESR Erythrocyte Sedimentation Rate